Biotech

All Articles

Biogen, UCB report stage 3 lupus succeed after falling short earlier test

.Biogen and UCB's bank on advancing right into stage 3 on the back of a failed study seeks to have p...

Aptadir hopes brand-new RNA inhibitors may turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has introduced with the assurance that its own pipeline of pre...

Wave surfs DMD results to regulators' doors, sending out stock up

.Surge Life Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) rese...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma laye...

Achilles trickles cell therapy plan, braces for unemployments after missing out on 'office viability' targets

.Achilles Therapies has wrecked its own technique. The English biotech is quiting working on its own...

Aligos declares phase 2 MASH succeed, lowering liver fat approximately 46%

.Aligos Rehabs is actually advertising a midstage win in metabolic-dysfunction associated steatohepa...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually received a substantial boost com...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Possessing actually gathered up the united state liberties to Capricor Therapeutics' late-stage Duc...

FDA fragments adcomm for Applied's uncommon illness medicine

.After pushing back the decision meeting for Applied Rehabs' metabolic ailment medication govorestat...

Novo inks $600M NanoVation bargain to examine hereditary medicines ex-liver

.Novo Nordisk is proceeding its press right into hereditary medications, accepting pay NanoVation Th...